A large 2026 analysis of more than 9,000 patients found that people who stopped semaglutide or tirzepatide regained an average of nearly 2 pounds a month
Currently, there are high-protein foods on the market designed to prevent mass muscle loss as people lose weight
Semaglutide (Ozempic and Wegovy) Semaglutide is the most widely used GLP-1 receptor agonist for weight loss
A 2022 study published in The Journal of Clinical Endocrinology & Metabolism found that patients with type 2 diabetes using GLP-1 medications reported lower levels of depression and anxiety symptoms (Lee et al., 2022)
In studies, Wegovy led to average weight loss of around 15 percent of starting body weight when combined with lifestyle changes
Over the course of two years, Emma saw significant improvements in her insulin sensitivity, lipid profile, and overall metabolic health, reducing her risk of developing related comorbidities